DIAGNOSTIC REPORT *OD12308254173*

MRN : IHL1045307 Order No : OD12308254173

Patient Name : MR. GIAS UDDIN ANSARY Collected : 03/08/23 08:42 AM
Age / Gender : 58Y 11M 19D / Male Received : 03/08/23 08:59 AM
Ref. Doctor : PROF. DR M.A FAIZ MBBS,FCPS (Medicine) PHD (UK) FRC Reported : 03/08/23 10:00 AM
Report No : 12308511935 BED No :
LAB ID : 12308412623 Status : FINAL
CLINICAL BIOCHEMISTRY & IMMUNOLOGY
LIPID PROFILE -SERUM
Parameter Result Unit Flag Action Limit Method

CHOLESTEROL-SERUM 135 mg/dL Desirable : <200 CHO-POD

Borderline High : 200-239
High : >240

TRIGLYCERIDES-SERUM 86 mg/dL Normal : <150 GPO-POD

Borderline High: 150 - 199
High : 200 - 499
Very High : >500

HDL CHOLESTEROL-SERUM 37 mg/dL L Low : <40 Enzymatic

High : >60 Immunoinhibition

LDL CHOLESTEROL-SERUM 79 mg/dL Optimal : <100 Enzymatic

Near Optimal/Above Optimal Selective
: 100-129 Protection
Borderline High : 130-159
High : 160-189
Very High : >190

VLDL CHOLESTEROL-SERUM 17 mg/dL Upto 30 Calculated

NON-HDL CHOLESTEROL 98 mg/dL 30 mg/dL higher than LDL Calculated

goal

ATHEROSCLEROSIS INDEX 3.6 Low Risk : <4.5 Calculated

Average Risk : 4.5-7.1
Moderate Risk : 7.2-11.0
High Risk : >11.0

Interpretive Guide
Although LDL cholesterol is the primary target of therapy, other lipid risk factors besides elevated LDL affect coronary heart
disease (CHD) risk. Among these are low HDL cholesterol, elevated triglyceride (especially VLDL remnants),and possibly
small LDL particles. This "lipid triad" has been called Atherogenic Dyslipidemia. It commonly occurs as one component of
the metabolic syndrome. In persons with high triglycerides, ATP III (Adult treatment panel III) identifies the sum of LDL
cholesterol + VLDL cholesterol ( termed non-HDL cholesterol) which represents Atherogenic Cholesterol. non-HDL
cholesterol thus an important parameter used as secondary target of therapy (after LDL cholesterol) when triglycerides
are elevated.
Powered by: MYSOFT Ltd.

Caution
Serum lipid concentrations and lipoprotein patterns are labile and affected by eating, smoking, alcohol intake, stress and
changes in posture. Although plasma cholesterol concentrations are not significantly affected after a fatty meal, plasma
triglyceride concentrations are. Therefore, specimen for analysis should be taken after the patient has fasted for 09 to

Pranab Raj Barua Rana PROF. DR. NASREEN CHOWDHURY

Medical Technologist MBBS, MD, FCPS
Sr. Consultant
Clinical Biochemistry & Immunology

Printed by : RATAN405 Printed Date 03/08/2023 01:03:16 PM Page 1 of 2

 *OD12308254173*
MRN : IHL1045307 Order No : OD12308254173
Patient Name : MR. GIAS UDDIN ANSARY Collected : 03/08/23 08:42 AM
Age / Gender : 58Y 11M 19D / Male Received : 03/08/23 08:59 AM
Ref. Doctor : PROF. DR M.A FAIZ MBBS,FCPS (Medicine) PHD (UK) FRC Reported : 03/08/23 10:00 AM
Report No : 12308511935 BED No :
LAB ID : 12308412623 Status : FINAL
CLINICAL BIOCHEMISTRY & IMMUNOLOGY
LIPID PROFILE -SERUM
12 hours. Lipoprotein concentrations, like those of large particles, are affected by venous stasis and posture.The plasma
cholesterol concentration may be up to 10% higher in the upright than the recumbent position and that of triglyceride may
change slightly more than this. A standardized collection procedure is important if serial estimations to assess the effect
of the treatment are used. Stress may affect plasma lipid concentrations and investigation of hyperlipidaemia should be
deferred for three months after a myocardial infarction, a major operation, or any serious illness. However, samples taken
within 12 hours of a myocardial infarct seem to reflect "true" values. Result can be falsely decreased in patients with
elevated levels of N-acetyl-p-benzoquinone imine (NAPQI)-a metabolite of acetaminophen, N-acetylcysteine (NAC), and
metamizole.
Legend: H-High, HC-High Critical, L-Low, LC- Low Critical
----------------- End of Report -----------------
Powered by: MYSOFT Ltd.

Pranab Raj Barua Rana PROF. DR. NASREEN CHOWDHURY

Medical Technologist MBBS, MD, FCPS
Sr. Consultant
Clinical Biochemistry & Immunology

Printed by : RATAN405 Printed Date 03/08/2023 01:03:16 PM Page 2 of 2